多灶性胶质母细胞瘤:切除与活检的加权生存分析
采用逆概率治疗加权调整年龄、病灶数、卫星瘤体积等协变量后,切除组中位总生存优于活检组(p=0.026),无进展生存无显著差异(p=0.411);切除程度≥85%与中位总生存提高显著相关(p=0.016)。
要点
- 多灶性胶质母细胞瘤切除最大强化病灶与中位总生存改善相关(p=0.026)。
- 切除程度≥85%与中位总生存显著提高相关(p=0.016)。
- 切除与活检的无进展生存无显著差异(p=0.411)。
核心结论
- 切除多灶性胶质母细胞瘤最大强化病灶可能带来生存获益,切除程度越高生存越好。
研究设计与样本
- 采用逆概率治疗加权(IPTW)调整年龄、病灶数、卫星瘤体积、术前总瘤体积、播散程度和位置后行Kaplan-Meier生存分析。
主要发现
- IPTW分析显示切除组中位总生存优于活检组(p=0.026),无进展生存无显著差异(p=0.411)。
- 切除程度≥85%与中位总生存显著提高相关(p=0.016)。
关键数值与推荐
- 切除程度≥85%与中位总生存显著提高相关(p=0.016)。
临床怎么用
- 对多灶性胶质母细胞瘤可考虑积极切除最大强化病灶以改善总生存。
- 手术决策可参考切除程度≥85%与生存获益相关的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECT: Diffuse tumor invasion in multifocal/multicentric GBM (mGBM) often foreshadows poor survival outcome. The correlation between extent of resection in gliomas and patient outcome is well described. The objective of this study was to assess the effect of gross total resection compared to biopsy for mGBM on patient overall survival and progression free survival. METHODS: Thirty-four patients with mGBM received either biopsy or resection of their largest enhancing lesion from 2011 to 2019. Relevant demographic, peri-operative, and radiographic data were collected. Tumor burden and extent of resection was assessed through measurement of pre-operative and post-operative contrast-enhancing volume. An adjusted Kaplan-Meier survival analysis was conducted using inverse probability of treatment weighting (IPTW) to account for the covariates of age, number of lesions, satellite tumor volume, total pre-operative tumor volume, degree of spread, and location. RESULTS: Thirty-four patients were identified with sixteen (47.1%) and eighteen (52.9%) patients receiving resection and biopsy respectively. Patients receiving resection exhibited greater median overall survival but not progression free survival compared to biopsy on IPTW analysis (p = 0.026, p = 0.411). Greater than or equal to 85% extent of resection was significantly associated with increased median overall survival (p = 0.016). CONCLUSION: Overall, our study suggests that resection of the largest contrast-enhancing lesion may provide a survival benefit. Our volumetric analysis suggests that a greater degree of resection results in improved survival. Employing IPTW analysis, we sought to control for selection bias in our retrospective analysis. Thus, aggressive surgical treatment of mGBM may offer improved outcomes. Further clinical trials are needed.
引用
- Di L, Heath RN, Shah AH, et al. Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis. J Neurooncol. 2020. PMID: 32394325. doi:10.1007/s11060-020-03508-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。